Surgical Robots Market Size and Share
Market Overview
| Study Period | 2019 - 2030 |
|---|---|
| Market Size (2025) | USD 8.31 Billion |
| Market Size (2030) | USD 12.83 Billion |
| Growth Rate (2025 - 2030) | 9.07% CAGR |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | High |
Major Players
*Disclaimer: Major Players sorted in no particular order Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0. |
|
Surgical Robots Market Analysis by Mordor Intelligence
The surgical robots market size is estimated to be USD 8.31 billion in 2025 and is projected to reach USD 12.83 billion by 2030, growing at a 9.07% CAGR throughout the forecast period. Demand stems from aging populations seeking precision in joint replacement, hospital consolidation that favors high-utilization platforms, and rapid reimbursement expansion in the United States and China. Artificial intelligence (AI) modules are expanding the reach of robots into soft-tissue, neurosurgical, and cardiac domains, while portable designs position the technology for use in ambulatory settings. The intensifying consolidation, typified by Karl Storz’s 2024 acquisition of Asensus Surgical, signals a maturing competitive arena geared toward performance-guided and data-rich systems. Regulatory costs under the EU Medical Device Regulation (MDR) and periodic device recalls inject caution, but overall momentum remains firmly positive.[1]Karl Storz, “Acquisition of Asensus Surgical by KARL STORZ,” karlstorz.com
Key Report Takeaways
- By component, surgical systems accounted for 65% of 2024 revenue, whereas services are expected to expand at a 12.5% CAGR by 2030.
- By area of surgery, gynecology led with 32% revenue share in 2024; orthopedics is forecast to accelerate at a 13.2% CAGR through 2030.
- By end-user, hospitals accounted for 85% of the surgical robots market share in 2024, while ambulatory surgical centers are projected to advance at a 15% CAGR through 2030.
- By product mobility, non-portable platforms commanded 90% of 2024 revenue, whereas portable solutions are projected to grow at a 24.8% CAGR by 2030.
- By geography, North America contributed 45% of the 2024 revenue; the Asia-Pacific region is projected to expand at a 12.1% CAGR by 2030.
Global Surgical Robots Market Trends and Insights
Drivers Impact Analysis
| Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Surge in orthopedic-robot adoption driven by Europe and Japan's aging population | +2.10% | Europe, Japan, developed APAC | Medium term (2-4 years) |
| AI-enabled vision and haptics expanding complex soft-tissue indications | +1.80% | Global, with early adoption in North America and EU | Long term (≥ 4 years) |
| US-CMS and China-NRDL reimbursement approvals improving ROI | +1.50% | United States, China, spill-over to emerging markets | Short term (≤ 2 years) |
| Hospital-consolidation budgets favoring high-utilization robotic platforms | +1.30% | North America and EU primarily | Medium term (2-4 years) |
| ASC shift in the US spurring demand for compact robots | +1.00% | United States, early adoption in Canada | Short term (≤ 2 years) |
| Med-tech localization funds (India PLI, EU IPCEI) boosting manufacturing | +0.90% | India, EU Member States, select emerging markets | Long term (≥ 4 years) |
| Source: Mordor Intelligence | |||
Surge in Orthopedic-Robot Adoption Driven by Europe and Japan’s Aging Population
Germany expects knee replacement rates to rise by 55% by 2040, underscoring the need for precise implant placement, which robotic platforms can deliver. Japanese hospitals mirror this demographic pressure, spurring Stryker to expand Mako installs across major networks. Clinical workflows focus on reproducible bone resection and alignment, thereby reducing the risk of revision in elderly cohorts. High procedure volumes create favorable payback, prompting national health systems to prioritize orthopedic robots. The demographic tailwind is, therefore, a structural, independent growth pillar for the surgical robots market.
AI-Enabled Vision and Haptics Expanding Complex Soft-Tissue Indications
Computer vision now identifies critical anatomy in real-time, while force-feedback sensors modulate grip to minimize tissue trauma. Johns Hopkins engineers have demonstrated that robots can learn to suture at a human-level proficiency by watching videos. Such capabilities open neurosurgical and cardiac use cases where dexterity thresholds were formerly prohibitive. Hospitals prize the prospect of predictive analytics that flag errors before they occur, aligning with the imperatives of value-based care. AI expansion thus upgrades the surgical robots market from a capital asset to a continuous-learning clinical partner.
US-CMS and China-NRDL Reimbursement Approvals Improving ROI
UnitedHealthcare now defines robotic assistance as integral to core procedures, thereby eliminating ambiguity in separate billing. China’s National Reimbursement Drug List likewise began covering robotic surgeries in top-tier cities, with 64% of units deployed in 2024 sourced from domestic manufacturers. Hospitals consequently lock in predictable payment schedules, enabling multi-platform purchases that once faced pushback at the board level. Robust reimbursement removes a principal barrier to scaling the surgical robots market size across both high- and middle-income nations.
Hospital-Consolidation Budgets Favouring High-Utilization Platforms
Mega-systems, such as HCA, negotiate fleet deals that drive down per-procedure costs and increase training efficiencies. Intuitive reports 2.63 million da Vinci cases in 2024, a volume that justifies routine capital upgrades. Academic centers alike test emerging devices, accelerating validation cycles. Consolidated procurement thus widens the moat for feature-rich systems and constrains prospects for niche challengers unless they demonstrate cross-specialty throughput.[2]European Commission, “€1 billion of State Aid for IPCEI Med4Cure,” ec.europa.eu
Restraints Impact Analysis
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Long capital pay-back in low-volume MEA hospitals | -1.20% | Middle East & Africa, select emerging markets | Medium term (2-4 years) |
| Device-recall incidents (2022-24) denting surgeon confidence | -0.90% | Global, with concentrated impact in North America & EU | Short term (≤ 2 years) |
| Shortage of fellowship-trained robotic surgeons in Tier-2 cities | -0.70% | Emerging markets, secondary metropolitan areas globally | Long term (≥ 4 years) |
| EU-MDR 2017/745 compliance costs delaying launches | -0.60% | European Union, with spillover to global product development | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
Long Capital Pay-Back in Low-Volume MEA Hospitals
Resource-constrained settings in Africa struggle to reach the 200-case annual threshold that justifies robot ownership, forcing facilities to weigh alternative investment priorities. Service contracts often involve overseas engineers, inflating operational outlays. Although Saudi centers report 98% survival rates in robotic cardiac surgery, broad regional adoption remains tepid until financing models evolve.
Device-Recall Incidents (2022-24) Denting Surgeon Confidence
Asensus Senhance, Zimmer Biomet ROSA, and Stryker Mako have each faced Class I or Class II recalls due to software or kinematic faults. Hospitals now impose longer evaluation timelines and demand extensive post-market surveillance data. Temporary slowdowns harm emerging entrants most acutely, as established vendors wield larger safety datasets to reassure credentialing committees.[3]U.S. FDA, “Class I Recall: Asensus Surgical Senhance System,” fda.gov
Segment Analysis
By Component: Systems Anchor Revenue While Services Accelerate
Surgical systems generated 65% of 2024 revenue, a testament to the capital-intensive nature of platform acquisitions. Instruments and accessories produce steady procedure-linked cash flows, but services are projected to rise 12.5% annually to 2030 as hospitals require algorithm updates, cybersecurity patches, and multi-specialty training. The intuitive introduction of the fifth-generation da Vinci triggered a significant refresh wave. That upgrade cycle elevates the surgical robots market size for hardware while underpinning the growth of recurring services.
Service contracts now bundle predictive-maintenance analytics, extending uptime and smoothing OR scheduling. AI-enabled modules require continuous calibration to maintain regulatory compliance, thereby embedding vendors more deeply into hospital IT ecosystems. Training revenue expands alongside surgeon credentialing mandates, particularly in emerging markets where fellowship capacity lags. The dual-engine dynamic positions services as the long-run margin accelerator within the broader surgical robots market.
Note: Segment shares of all individual segments available upon report purchase
By Area of Surgery: Gynaecology Leads While Orthopaedics Accelerates
Gynaecological procedures generated 32% of the revenue in 2024, leveraging decades of minimally invasive adoption for hysterectomy and myomectomy procedures. Clear evidence of reduced blood loss and shorter stays makes robotic intervention a standard of care across many U.S. sites. In contrast, orthopaedics comprises the fastest-growing segment, advancing 13.2% annually due to aging population implant demand. Orthopaedics, therefore, is expected to command an expanding share of the surgical robots market by 2030, according to projections.
The innovation pace in joint-replacement navigation positions robots as guarantors of alignment, thereby mitigating the need for revision surgeries. Zimmer Biomet’s tie-up with Think Surgical on the TMINI handheld robot illustrates ergonomic evolution. Neurosurgery and cardiac applications remain nascent but benefit from AI-guided micro-manipulation. Diversity of indications cushions cyclicality, distributing procedural risk across specialties and reinforcing resilience in the surgical robots market.
By End-User: Hospitals Dominate While ASCs Surge
Hospitals performed 85% of robotic cases in 2024, given their capacity to amortize platforms over multiple departments. Large systems negotiate fleet discounts and harmonize credentialing, generating scale economies. Cleveland Clinic and NYU actively test micro-surgery robots such as Symani, highlighting tertiary-center leadership. Consequently, hospitals are expected to maintain the lion’s share of the surgical robots market as of 2025.
Ambulatory surgical centers (ASCs), however, exhibit a 15% CAGR through 2030 as payors shift lower-acuity procedures out of inpatient settings. Sg2 forecasts 44 million ASC cases by 2034. Portable robots meet ASC requirements for fast room turnover and limited floor space, encouraging device makers to engineer compact, cost-efficient configurations. Rising ASC penetration, therefore, offers an outsized incremental lift to overall surgical robots market growth.
Note: Segment shares of all individual segments available upon report purchase
By Product Mobility: Non-Portable Systems Prevail While Portable Gains Momentum
Traditional cart-based robots occupied 90% of revenue in 2024. These systems offer extensive instrument libraries, integrated imaging, and multi-arm dexterity, which are well-suited for complex, multi-hour surgeries. Their size and infrastructure requirements anchor them to fixed OR suites, ensuring a stable installed base that continues to underpin the surgical robots market.
Portable solutions, registering a blistering 24.8% CAGR to 2030, respond to outpatient and modular-OR trends. Moon Surgical’s Maestro and CMR Surgical’s Versius embody modularity and transportability. Handheld adjuncts such as the TMINI intensify competition on ergonomics and price, unlocking budgets at smaller centers. This design shift could recalibrate the surgical robots market toward higher unit volumes but lower average selling prices, thereby broadening accessibility.
Geography Analysis
North America retained 45% of 2024 revenue, propelled by strong reimbursement and early adopter surgeon communities. More than 2.63 million procedures utilized da Vinci systems in 2024, emphasizing procedure-density economies. The surgical robots market size for the United States alone is forecast to reach double-digit billions by the end of the decade as ASC penetration increases.
Europe ranks second, driven by Germany’s surge in orthopaedic demand and the EU’s EUR 1 billion (USD 1.15 billion) Med4Cure program. Yet MDR compliance costs dampen speedy platform launches, moderating near-term growth. The surgical robots market finds steadier traction in France, Italy, and the Nordics, where centralized procurement promotes platform standardization.
The Asia-Pacific region exhibits the fastest growth, with a 12.1% CAGR through 2030. China’s 64% domestically manufactured deployment mix validates the depth of its local manufacturing capabilities. India’s Production-Linked Incentive scheme pairs tariffs with subsidies, cultivating a nascent export hub for robotic subsystems. Japan’s super-aged demographic drives steady orthopaedic robot purchases, while South Korea and Australia leverage strong digital infrastructure for rapid adoption. Collectively these markets add significant weight to the global surgical robots market trajectory.[4]Press Information Bureau of India, “PLI Scheme Increases Medical Device Production,” pib.gov.in
Competitive Landscape
Intuitive Surgical anchors soft-tissue dominance, leveraging a 25-year install base and proprietary instrument ecosystem. In orthopaedics, fragmentation prevails. Stryker, Zimmer Biomet, and Think Surgical vie for implant-specific niches, while Medtronic refines the Hugo platform through targeted acquisitions such as Fortimedix. Karl Storz’s 2024 buyout of Asensus embeds performance-guided AI into a broader endoscopy portfolio, illustrating the momentum of consolidation.
White-space opportunities center on procedure-specific systems. ForSight Robots secured USD 125 million to progress cataract surgery automation, while the University of Utah prototype achieves 1-micrometer retinal precision.
Competitive differentiation now hinges on AI-driven skill assessment and real-time error prediction, elements that raise switching costs for hospital purchasers. Vendor strategies increasingly bundle data services, creating embedded revenue beyond hardware and deepening barriers to entry in the surgical robots market.
Surgical Robots Industry Leaders
-
Intuitive Surgical, Inc.
-
Stryker Corporation
-
Johnson & Johnson (Auris + DePuy)
-
Medtronic PLC
-
Zimmer Biomet Holdings, Inc.
- *Disclaimer: Major Players sorted in no particular order
Recent Industry Developments
- March 2025: Intuitive Surgical reported peer-reviewed evidence that Force Feedback in da Vinci 5 lowers tissue trauma by 43%, with global rollout planned for 2025.
- March 2025: Monogram robot received FDA clearance, while Vicarious Surgical announced supplier-related delays.
- February 2025: University of Utah engineers unveiled a head-mounted retinal robot achieving 1-micrometer movements.
- November 2024: Johns Hopkins demonstrated AI-trained suturing robots performing at human-equivalent levels.
Global Surgical Robots Market Report Scope
Robotic surgery is performed by a particularly trained surgeon through tiny incisions. Conditions affecting the bladder, prostate, heart, digestive system, and more can be treated using robotic surgery. The advantages are less blood loss, shorter hospital stays, and speedier recovery. The capacity of surgical robots to precisely manipulate surgical equipment in a restricted operating room is helpful for minimally invasive surgery. Two tiny gripping manipulators, a stiff neuro endoscope, a suction tube, and a perfusion tube, make up the micromanipulator.
The surgical robots market is segmented by component (surgical system, accessory, and service), area of surgery (gynecological surgery, cardiovascular, neurosurgery, orthopedic surgery, laparoscopy, and urology), and geography (North America, Europe, Asia Pacific, Rest of the World). The market sizes and forecasts are provided in terms of value in USD for all the above segments.
| Surgical Systems |
| Instruments and Accessories |
| Training |
| Services (Maintenance |
| Gynecological |
| Urological |
| Orthopedic |
| Neurosurgery |
| Cardiovascular |
| General and Laparoscopic |
| Thoracic |
| Other Specialties |
| Hospitals |
| Ambulatory Surgical Centers |
| Specialty Clinics |
| Mobility |
| Non-portable Systems |
| Portable/Cart-based Systems |
| North America | United States |
| Canada | |
| Mexico | |
| Europe | United Kingdom |
| Germany | |
| France | |
| Italy | |
| Rest of Europe | |
| Asia-Pacific | China |
| Japan | |
| India | |
| South Korea | |
| Rest of Asia-Pacific | |
| Middle East | Israel |
| Saudi Arabia | |
| United Arab Emirates | |
| Turkey | |
| Rest of Middle East | |
| Africa | South Africa |
| Egypt | |
| Rest of Africa | |
| South America | Brazil |
| Argentina | |
| Rest of South America |
| By Component | Surgical Systems | |
| Instruments and Accessories | ||
| Training | ||
| Services (Maintenance | ||
| By Area of Surgery | Gynecological | |
| Urological | ||
| Orthopedic | ||
| Neurosurgery | ||
| Cardiovascular | ||
| General and Laparoscopic | ||
| Thoracic | ||
| Other Specialties | ||
| By End-user | Hospitals | |
| Ambulatory Surgical Centers | ||
| Specialty Clinics | ||
| By Product | Mobility | |
| Non-portable Systems | ||
| Portable/Cart-based Systems | ||
| By Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Europe | United Kingdom | |
| Germany | ||
| France | ||
| Italy | ||
| Rest of Europe | ||
| Asia-Pacific | China | |
| Japan | ||
| India | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Middle East | Israel | |
| Saudi Arabia | ||
| United Arab Emirates | ||
| Turkey | ||
| Rest of Middle East | ||
| Africa | South Africa | |
| Egypt | ||
| Rest of Africa | ||
| South America | Brazil | |
| Argentina | ||
| Rest of South America | ||
Key Questions Answered in the Report
What is the current size of the surgical robots market?
The surgical robots market generated USD 8.31 billion in 2025 and is projected to reach USD 12.83 billion by 2030.
Which surgical specialty accounts for the largest share of robotic procedures?
Gynaecological surgeries lead with 32% of 2024 revenue, supported by established minimally invasive protocols and strong clinical evidence.
Why are ambulatory surgical centers adopting robots so quickly?
Predictable reimbursement frameworks and compact platform designs allow ASCs to offer high-precision procedures while maintaining rapid room turnover.
How are AI capabilities influencing future surgical robots?
AI enhances vision, haptics, and predictive analytics, enabling robots to recognize anatomy, adjust force in real time, and flag potential errors before they occur.
What regions present the fastest growth opportunities?
Asia-Pacific shows a 12.1% forecast CAGR to 2030, driven by China’s domestic manufacturing surge, India’s PLI incentives, and Japan’s aging demographics.
What is the main barrier to adoption in emerging markets?
Low procedure volumes in many MEA hospitals extend pay-back periods, while shortages of trained surgeons and high service costs impede wider deployment.
How is consolidation shaping the competitive landscape?
Large health systems negotiate fleet deals, favour data-rich platforms, and drive market share toward vendors that can support multi-specialty, high-throughput usage.
Page last updated on:
